Estatísticas para RT 2105 2020 - AFLIBERCEPTE (EYLLA), BEVACIZUMABE (AVASTIN). LUCENTIS - edema macular diabético - NATJUS TJMG

Total de visitas

views
RT 2105 2020 - AFLIBERCEPTE (EYLLA), BEVACIZUMABE (AVASTIN). LUCENTIS - edema macular diabético - NATJUS TJMG 0

Total visitas por mês

views
January 2025 0
February 2025 0
March 2025 0
April 2025 0
May 2025 0
June 2025 0
July 2025 0

Visitas Arquivos

views
RT 2020.0002105 - Aflibercepte.pdf 3